Preclinical PET imaging of the developing fetus during pregnancy: Current state and future potential
- PMID: 40367390
- PMCID: PMC12078245
- DOI: 10.1177/0271678X251340510
Preclinical PET imaging of the developing fetus during pregnancy: Current state and future potential
Abstract
During pregnancy, the fetus is subject to complex interactions of biological and environmental factors that can influence developmental trajectories even into adulthood. Although several factors, such as maternal malnutrition and substance abuse, have been associated with offspring development, the mechanisms through which short- and long-term effects manifest in the fetus are not well understood. To this end, positron emission tomography (PET) imaging using preclinical models has been a promising and underutilized technique for investigating fetal exposure and physiology in utero with minimal invasiveness. Herein, we review the application of PET imaging to fetal medicine and survey the limitations and opportunities for future longitudinal studies of development. Over the past two decades, several studies have utilized preclinical PET in quantitative studies of maternal-fetal exchange dynamics of pharmaceuticals, environmental toxins, or drugs of abuse. Another application has shown [18F]FDG PET to be a potential biomarker for fetal glucose transport, hypoxia, and brain function in utero. In contrast, only a few studies have employed reversibly binding radioligands to quantify protein markers of dopaminergic signaling and synaptic density in the fetal brain. As PET technology continues to improve, our review highlights a future role for PET in longitudinal studies of fetal health and development.
Keywords: PET; brain function; fetal imaging; in utero; prenatal.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures



Similar articles
-
Maternal-fetal in vivo imaging: a combined PET and MRI study.J Nucl Med. 2003 Sep;44(9):1522-30. J Nucl Med. 2003. PMID: 12960202
-
Maternal and fetal 11C-cocaine uptake and kinetics measured in vivo by combined PET and MRI in pregnant nonhuman primates.J Nucl Med. 2005 Feb;46(2):312-20. J Nucl Med. 2005. PMID: 15695792
-
Imaging the fetal nonhuman primate brain with SV2A positron emission tomography (PET).Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3679-3691. doi: 10.1007/s00259-022-05825-6. Epub 2022 May 28. Eur J Nucl Med Mol Imaging. 2022. PMID: 35633376 Free PMC article.
-
Adverse Prenatal Exposures and Fetal Brain Development: Insights From Advanced Fetal Magnetic Resonance Imaging.Biol Psychiatry Cogn Neurosci Neuroimaging. 2022 May;7(5):480-490. doi: 10.1016/j.bpsc.2021.11.009. Epub 2021 Nov 27. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022. PMID: 34848383 Review.
-
The placenta in fetal thyroid hormone delivery: from normal physiology to adaptive mechanisms in complicated pregnancies.J Matern Fetal Neonatal Med. 2020 Nov;33(22):3857-3866. doi: 10.1080/14767058.2019.1586875. Epub 2019 Mar 19. J Matern Fetal Neonatal Med. 2020. PMID: 30821546 Review.
References
-
- Berglund L, Halldin C, Lilja A, et al.. 11C‐methionine kinetics in pregnant rhesus monkeys studied by positron emission tomography: a new approach to feto‐maternal metabolism. Acta Obstet Gynecol Scand 1984; 63: 641–645. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous